Apr 1 |
Apellis Pharmaceuticals to Host a Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference
|
Mar 28 |
Apellis Pharmaceuticals (APLS) Down 8.7% Since Last Earnings Report: Can It Rebound?
|
Mar 19 |
Insider Sell: Chief Business & Strategy Officer Mark Delong Sells 9,913 Shares of Apellis ...
|
Mar 17 |
30 Biggest Biotechnology Companies in the World
|
Mar 15 |
Peering Into Apellis Pharmaceuticals's Recent Short Interest
|
Mar 14 |
Apellis Pharmaceuticals Inc (APLS) CTO Nur Nicholson Sells 11,220 Shares
|
Mar 11 |
Apellis Pharmaceuticals Inc's Chief Scientific Officer Pascal Deschatelets Sells 69,107 Shares
|
Mar 11 |
Apellis Appoints Leading Expert Dr. Philip Ferrone as Chief Medical Retina Advisor
|
Feb 28 |
Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) Q4 2023 Earnings Call Transcript
|
Feb 28 |
Apellis (APLS) Q4 Earnings Miss, Revenues Meet Estimates
|